Prognostic Factors for the Survival of Surgically Treated Patients for Non-Small Cell Lung Cancer

Authors: Fernandes, Oswaldo J.C.B.; Almgren, Stig-olof; Thaning, Lars; Filbey, Derek; Helsing, Martin; Karlsson, Mats; Magnusson, Anders; Souza, Domingos

Source: Acta Oncologica, Volume 42, Number 4, June 2003 , pp. 338-341(4)

Publisher: Informa Healthcare

Buy & download fulltext article:


Price: $55.00 plus tax (Refund Policy)


The survival and outcome rates of 284 patients who underwent surgical treatment for non-small cell lung cancer were assessed retrospectively. Resectability rate was 94.1%, hospital mortality 3.9% (n=11) and the mortality rates in patients who underwent pneumonectomy or lobectomy were 8.9% and 0.6%, respectively. The overall 5-year survival was 43.6%. Female gender, earlier stages of disease and a complete resection were strongly predictive for a long-term survival. Women in stage IA disease had a 5-year survival rate of 92.7%. The 5-year survival rate for patients in stages IIIA and N2 disease who underwent a complete resection was 21.9%, and 9% for those who did not undergo a complete resection. It is concluded that the best surgical results were observed in women who were operated on at an early stage of disease. A complete resection also contributed to a better outcome, even for patients in stage IIIA and N2 disease.

Document Type: Research Article


Publication date: June 1, 2003

More about this publication?


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page